M&A to Market Share: How Strategic Consulting Accelerates Healthcare Growth

There is a belief circulating in healthcare boardrooms that growth requires scale; that the fastest path to market share is a well-timed acquisition. Buy a competitor. Absorb a physician group. Merge your way to relevance. Sometimes that's true. More often, it's expensive wishful thinking. The organizations that have built durable, defensible market positions in the last five years haven't just acquired their way there. They've strategized their way there, and the ones who've done it fastest have had the right advisory partners in the room before the ink dried on any deal. M&A Is Accelerating- But So Is the Risk Healthcare deal value surged 56% in the first half of 2025, even as overall deal volume remained flat, reflecting a clear shift toward larger, more strategic transactions rather than opportunistic volume plays.(KPMG) More than 75% of provider deals in 2025 were focused on consolidation plays, with an increasing proportion targeting healthcare services and technology capabilities to maximize the value of existing assets. (McKinsey & Company) That's a meaningful signal. Healthcare organizations aren't just buying market share anymore, they're buying strategic capability. The question is whether they have the frameworks to actually unlock value post-deal. Most don't. Eighty percent of executives say economic uncertainty is still influencing their M&A plans, and even the boldest acquirers are increasingly cautious about what comes after the transaction closes. This is precisely where strategic consulting earns its keep.

What Good Strategy Work Actually Does The most common misunderstanding about strategic consultants in healthcare is that they show up after the strategy is already set, to validate, package, and present. The finest ones arrive early, while the choices are still genuinely up for debate. Prior to an acquisition, they provide a detailed map of the competitive environment that allows you to distinguish between targets that genuinely move the needle and those that merely look nice on a slide. They provide the operational bridges during integration to stop the clinical and cultural fragmentation that destroys deal value more quickly than any market circumstance. After the deal: they hold the organization accountable to the growth thesis, measuring market share movement, referral pattern shifts, and margin improvement against the promise that justified the transaction. The global healthcare strategy consulting market generated $6.5 billion in 2024 and is growing at nearly 9% annually (Global Market Insights),not because organizations are in love with consultants, but because the complexity of competing in healthcare has outpaced what most internal teams can absorb alone. Strategy Is What Turns Acquisitions Into Advantage A deal gives you assets. Strategy gives you direction. Without the latter, the former is just overhead. The most successful healthcare organizations entering 2026 are prioritizing deals that enhance operational efficiency, reduce costs, and improve patient outcomes. That distinction matters enormously. It's the difference between market share that compounds over time and market share that erodes the moment a sharper competitor enters your geography. At Modality Global Advisors, we work with healthcare leaders who are confusing activity with progress. We help them define what growth actually looks like for their organization, identify the moves, organic and inorganic, that get them there, and build the operational architecture to make it stick. Because the goal was never the deal. The goal was always what comes after it.